Ketones (spefically beta-hydroxybutyrate) have shown to inhibit NLRP3 inflammasome activation, which is a key pathological mechanism in COVID-19.
In a study of 175 COVID-positive patients in collaboration with Wenzhou Hospital in China, nearly all were identified as having hypokalemia (low serum potassium), likely due to the mechanisms of COVID-19 on ACE2 receptors and the renin-angiotensin system.
There has been quite a bit of kerfuffle about the workhorse nutrient vitamin D. We are getting pinged daily on whether it should be used or avoided in the COVID19 pandemic. I believe this question was fueled by a recent write-up mentioning an in vitro study showing that D can up-regulate certain cytokines.
Zinc is needed to slow viral RNA replication and it also regulates inflammatory cytokines. Anosmia and ageusia, as reported in COVID-19 and also common symptoms of flu, are classic signs of zinc defficiency.
Traditional Chinese Medicine (TCM) is used in all settings in China for COVID19, with preliminary outcome data very, very strong. Indeed, outcome data using TCM for prevention and treatment of SARS Cov1 was equally strong. Listen to one of the most important and timely conversations I’ve had to date on New Frontiers with Dr. John Chen, one of the world’s leading experts in TCM (with western pharma training).